ID
16052
Descripción
Documentation part: Clinical evaluation & outcome evaluation A Randomised, Observer-blind, Multicentre, Non-inferiority, Comparative, Phase III Study of the Safety and Efficacy of Topical 1% SB-275833 Ointment, Applied Twice Daily for 5 Days, versus Topical 2% Sodium Fusidate Ointment Applied Three Times Daily for 7 Days in the Treatment of Adult and Paediatric Subjects with Impetigo. ClinicalTrials.gov Identifier: NCT00133874 Other Study ID Numbers: TOC100224 Responsible Party: GlaxoSmithKline
Palabras clave
Versiones (3)
- 27/6/16 27/6/16 -
- 13/4/21 13/4/21 - Dr. rer. medic Philipp Neuhaus
- 17/11/21 17/11/21 -
Subido en
27 de junio de 2016
DOI
Para solicitar uno, por favor iniciar sesión.
Licencia
Creative Commons BY-NC 3.0
Comentarios del modelo :
Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.
Comentarios de grupo de elementos para :
Comentarios del elemento para :
Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.
Clinical evaluation & outcome evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Clinical evaluation & outcome evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
Descripción
Withdrawal
Descripción
Clinical outcome determination (OUT)
Descripción
Clinical success
Tipo de datos
text
Alias
- UMLS CUI [1]
- C0085565
Descripción
Clinical failure
Tipo de datos
text
Alias
- UMLS CUI [1]
- C3640841
Descripción
If "Yes", please specify if this was due to Primary or Secondary lesion:
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C3640841
- UMLS CUI [1,2]
- | C1402294
- UMLS CUI [2]
- C1519215
Descripción
Date of failure
Tipo de datos
date
Unidades de medida
- DDMONYYYY
Alias
- UMLS CUI [1,1]
- C0011008
- UMLS CUI [1,2]
- C3640841
Descripción
Unable to determine, please specify:
Tipo de datos
text
Alias
- UMLS CUI [1,1]
- C0085565
- UMLS CUI [1,2]
- C3845108
Similar models
Clinical evaluation & outcome evaluation Topical SB-275833 Ointment 1% For The Treatment Of Impetigo NCT00133874
| C1402294 (UMLS CUI [1,2])
C1519215 (UMLS CUI [2])
C3640841 (UMLS CUI [1,2])
C3845108 (UMLS CUI [1,2])